Onkologie. 2013:7(4):188-190

Systemic anticancer therapy of colorectal cancer

Jiří Tomášek, Jana Halámková
Masarykův onkologický ústav a LF MU Brno

Systemic and surgical treatment of colorectal cancer are basic modalities in the therapy of early and metastatic colorectal cancer. Targeted

therapy improves treatment options for metastatic colorectal cancer.

Keywords: colorectal cancer, targeted treatment

Published: October 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tomášek J, Halámková J. Systemic anticancer therapy of colorectal cancer. Onkologie. 2013;7(4):188-190.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Hofheinz RD, Wenz F, Post S et al. Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, noninferiority, phase 3 trial. Lancet Oncol 2012; 13: 579-588. Go to original source... Go to PubMed...
    2. Oliner, J. Douillard, S. Siena et al: Analysis of KRAS/NRAS and BRAF mutations in the phase III PRIME study of panitumumab (pmab) plus FOLFOX versus FOLFOX as first-line treatment (tx) for metastatic colorectal cancer (mCRC). konference ASCO 2013, abstrakt č. 3511. Go to original source...
    3. Bennouna J, Sastre J, Arnold D, et al. ML18147 Study Investigators. Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 tril. Lancet Oncology 2013. Go to original source... Go to PubMed...
    4. Modrá kniha: aktuální vydání dostupné na www.linkos.cz.
    5. Jan; 14 (1): 29-37. doi: 10.1016/S1470-2045(12)70477.

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.